1344346 BC Ltd. Announces Proposed Reverse Takeover by Bien Etre Ltd.

1344346 BC Ltd. Announces Proposed Reverse Takeover by Bien Etre Ltd.
RTO $40M

Financial Advisor to Bien Etre
February 2024

Vision Sensing Acquisition Corp. with Mediforum Co., Ltd

NASDAQ: VSACU, VSAC, VSACW

Vision Sensing Acquisition Corp. with Mediforum Co., Ltd
Merger $250 M

Sole Financial Advisor
January 2024

DACTA SG Pte. Ltd with DGL Investments No. 1 Inc.

TSXV: DGL.P

DACTA SG Pte. Ltd with DGL Investments No. 1 Inc.
RTO (Reverse Take Over)

Sole Advisor to Dacta SG Pte. Ltd
January 2024

Qiao Future Technology Co., Ltd.

NASDAQ: MMNT

Qiao Future Technology Co., Ltd.
Acquisition of Control Block

Sole Advisor
January 2024

Filament Health Corp.

OTCQB: FLHLF, NEO: FH, FSE: 7Qs

Filament Health Corp.
Cap Raise $4.4 M

Sole Advisor
December 2023

Aimei Health Technology Co. Ltd.

NASDAQ: AFJKU

Aimei Health Technology Co. Ltd.
IPO $60 M

Sole Advisor
December 2023

Fenbo

NASDAQ: FEBO

Fenbo
IPO $5 M

Financial Advisor
December 2023

DUET Acquisition Corp. with Fenix 360

NASDAQ: DUET

DUET Acquisition Corp. with Fenix 360
Merger $610 M


November 2023

Norient Advisors

Undisclosed buyer

Norient Advisors
Undisclosed amount

Sale
November 2023

AI Transportation Acquisition Corp.

NASDAQ: AITRU

AI Transportation Acquisition Corp.
IPO $60 M

Sole Advisor
November 2023

Data Knights Acquisition Corp. with OnedMedNet

NASDAQ: ONMD

Data Knights Acquisition Corp. with OnedMedNet
Merger $317 M

Sole Advisor to Data Knights
November 2023

Thunder Power with Feutune Light

NASDAQ: FLFV

Thunder Power with Feutune Light
Merger $600 M

Sole Advisor to Thunder Power
October 2023

Titan Pharmaceuticals

NASDAQ: TTNP

Titan Pharmaceuticals
PIPE $10 M

Sole Advisor
September 2023

Uniti Electric Vehicle Company

Uniti Electric Vehicle Company
$1.5M

Investment
September 2023

Environmental Solutions Group Holdings Ltd. with Genesis Unicorn Capital Corp.

NASDAQ: ESGL

Environmental Solutions Group Holdings Ltd. with Genesis Unicorn Capital Corp.
Merger $161M

Financial Advisor to ESG Holdings
August 2023

Titan Pharmaceuticals

NASDAQ: TTNP

Titan Pharmaceuticals
Block share purchase $4.6M

Sole Advisor
July 2023

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission